June 27, 2019
MODAG in series A financing of €12 M to develop treatments for Parkinsonian Disorders
— Dr. Torsten Matthias appointed CEO, scientific founder Prof. Dr. Armin Giese joins as CSO —
— SERY technology in-licensed from Max-Planck Innovation GmbH to design next-generation candidate portfolio —